This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Stryker Dirección

Dirección controles de criterios 2/4

El CEO de Stryker's es Kevin Lobo , nombrado en Oct 2012, tiene una permanencia de 10.17 años. compensación anual total es $16.36M, compuesta por 8% salario y 92% primas, incluidas acciones y opciones de la empresa. posee directamente un 0.022% de las acciones de la empresa, por valor de €18.67M. La antigüedad media del equipo directivo y de la junta directiva es de 4.3 años y 5.3 años, respectivamente.

Información clave

Kevin Lobo

Chief Executive Officer (CEO)

US$16.4m

Compensación total

Porcentaje del salario del CEO	8.0%
Permanencia del CEO	10.2yrs
Participación del CEO	0.02%
Permanencia media de la dirección	4.3yrs
Promedio de permanencia en la Junta Directiva	5.3yrs

Actualizaciones recientes de la dirección

Recent updates

Análisis de compensación del CEO

¿Cómo ha cambiado la remuneración de Kevin Lobo en comparación con los beneficios de Stryker?
Fecha	Compensación total	Salario	Ingresos de la empresa
Sep 30 2022	n/a	n/a	US$2b
Jun 30 2022	n/a	n/a	US$2b
Mar 31 2022	n/a	n/a	US$2b
Dec 31 2021	US$16m	US$1m	US$2b
Sep 30 2021	n/a	n/a	US$2b
Jun 30 2021	n/a	n/a	US$2b
Mar 31 2021	n/a	n/a	US$1b
Dec 31 2020	US$13m	US$1m	US$2b
Sep 30 2020	n/a	n/a	US$2b
Jun 30 2020	n/a	n/a	US$2b
Mar 31 2020	n/a	n/a	US$2b
Dec 31 2019	US$15m	US$1m	US$2b
Sep 30 2019	n/a	n/a	US$3b
Jun 30 2019	n/a	n/a	US$4b
Mar 31 2019	n/a	n/a	US$4b
Dec 31 2018	US$14m	US$1m	US$4b
Sep 30 2018	n/a	n/a	US$1b
Jun 30 2018	n/a	n/a	US$1b
Mar 31 2018	n/a	n/a	US$1b
Dec 31 2017	US$14m	US$1m	US$1b
Sep 30 2017	n/a	n/a	US$2b
Jun 30 2017	n/a	n/a	US$2b
Mar 31 2017	n/a	n/a	US$2b
Dec 31 2016	US$13m	US$1m	US$2b
Sep 30 2016	n/a	n/a	US$2b
Jun 30 2016	n/a	n/a	US$2b
Mar 31 2016	n/a	n/a	US$2b
Dec 31 2015	US$10m	US$1m	US$1b

Compensación vs. Mercado: La compensación total de Kevin($USD16.36M) está por encima de la media de empresas de tamaño similar en el mercado German ($USD5.59M).

Compensación vs. Ingresos: La compensación de Kevin ha aumentado más de un 20% en el último año.

CEO

Kevin Lobo (57 yo)

10.2yrs

Permanencia

US$16,359,898

Compensación

Mr. Kevin A. Lobo has been the Chief Executive Officer of Stryker Corporation since October 1, 2012 and serves as its President since October 01, 2021. He serves as Chairman of the Board at The Advanced Me...

Equipo directivo

Nombre	Posición	Permanencia	Compensación	Propiedad
Kevin Lobo	Chairman	10.2yrs	US$16.36m	0.022% $ 18.7m
Glenn Boehnlein	VP & CFO	6.7yrs	US$6.02m	0.0052% $ 4.5m
Timothy Scannell	Executive Advisor	1.2yrs	US$8.12m	0.070% $ 61.0m
Viju Menon	Group President of Global Quality & Operations	4.7yrs	US$4.26m	0.0027% $ 2.4m
J. Pierce	Group President of MedSurg & Neurotechnology	4.3yrs	US$5.26m	0.011% $ 9.5m
Spencer Stiles	Group President of Orthopaedics & Spine	4.3yrs	US$5.19m	0.0098% $ 8.5m
William Berry	VP & Chief Accounting Officer	1.3yrs	sin datos	0.00033% $ 286.4k
Robert Cohen	CTO and VP of Global R&D - Joint Replacement	no data	sin datos	sin datos
Alan Douville	VP, Chief Information Officer & Chief Information Security Officer	4.3yrs	sin datos	sin datos
Jason Beach	Vice President of Investor Relations	less than a year	sin datos	sin datos
Robert Fletcher	VP & Chief Legal Officer	3.7yrs	US$2.24m	0.0019% $ 1.7m
Dana McMahon	VP & Chief Compliance Officer	no data	sin datos	sin datos

4.3yrs

Permanencia media

55yo

Promedio de edad

Equipo directivo experimentado: El equipo directivo de SYK se considera experimentado (4.3 años antigüedad media).

Miembros de la Junta

Nombre	Posición	Permanencia	Compensación	Propiedad
Kevin Lobo	Chairman	10.2yrs	US$16.36m	0.022% $ 18.7m
Lisa Skeete Tatum	Independent Director	2.6yrs	US$288.63k	0.00018% $ 156.2k
Howard Cox	Director Emeritus	4.6yrs	US$38.86k	sin datos
John Brown	Chairman Emeritus	no data	US$286.99k	5.3% $ 4.6b
Ronda Stryker	Independent Director	38.9yrs	US$288.63k	5.66% $ 4.9b
Mary Brainerd	Independent Director	5.3yrs	US$288.63k	0.0011% $ 980.8k
Srikant T. Datar	Independent Director	13.4yrs	US$288.63k	0.0087% $ 7.5m
Allan Golston	Independent Director	11.9yrs	US$338.44k	0.0028% $ 2.5m
Sherilyn S. McCoy	Lead Independent Director	4.6yrs	US$303.63k	0% $ 0
Rajeev Suri	Independent Director	4.6yrs	US$288.63k	0.00097% $ 841.9k
Giovanni Caforio	Independent Director	2yrs	US$288.63k	0.00018% $ 156.2k
Andrew Silvernail	Independent Director	9.1yrs	US$308.63k	0.00050% $ 434.0k

5.3yrs

Permanencia media

60yo

Promedio de edad

Junta con experiencia: La junta directiva de SYK se considera experimentada (5.3 años de antigüedad promedio).

This company listing is no longer active

Stryker Dirección

Dirección controles de criterios 2/4

Información clave

Actualizaciones recientes de la dirección

Stryker Corporation, Annual General Meeting, May 09, 2024

Stryker Corporation Announces Dr. Srikant Datar Will Retire from Board of Directors

Stryker Corporation Announces Board Changes

VP & CFO recently sold €536k worth of stock

Independent Director recently sold €229k worth of stock

VP & Chief Legal Officer recently sold €247k worth of stock

Recent updates

Stryker Releases Lifepak 35 Monitor/Defibrillator

Stryker Corporation (NYSE:SYK) agreed to acquire Artelon, Inc.

First European Announces That Surgeries Completed Using Stryker’s Gamma4 Hip Fracture Nailing System

Stryker Corporation Provides Earnings Guidance for the Full Year 2024

Stryker Corporation to Report Q1, 2024 Results on Apr 30, 2024

Stryker Launches Gamma4 Hip Fracture Nailing System in Europe

Stryker Announces the Launch of Prophecy Footprint, an Expansion of the Prophecy Surgical Planning System, Offering Comprehensive Surgical Planning Across the Entire Foot

Stryker Corporation Provides Earnings Guidance for the Year 2024

Stryker Corporation (NYSE:SYK) executed a binding offer to acquire Serf from SAS Menix.

Stryker Corporation, Annual General Meeting, May 09, 2024

Stryker Corporation Announces Dr. Srikant Datar Will Retire from Board of Directors

Stryker Corporation Declares Quarterly Dividend, Payable on January 31, 2024

Stryker Corporation Provides Earnings Guidance for the Full Year 2023

Stryker to Showcase Q Guidance System with Spine Guidance Software

Stryker Corporation to Report Q3, 2023 Results on Nov 02, 2023

Stryker Launches PROstep® MIS Lapidus, a New Minimally Invasive Surgical Option for Treating Patients with Bunions

Stryker Corporation Releases Its Next-Generation of Advanced Surgical Cameras

Stryker’S Pangea Systems Receive Food & Drug Administration Clearance

Stryker Corporation Provides Earnings Guidance for the Year 2023

Stryker Corporation to Report Q2, 2023 Results on Aug 03, 2023

Surgeons Successfully Complete First Surgical Cases Using Stryker’s Q Guidance System with Cranial Guidance Software

Stryker Corporation Declares Quarter Dividend, Payable on July 31, 2023

Stryker’s Q Guidance System for Cranial Applications Receives FDA Clearance

Stryker Declares Quarterly Dividend, Payable on April 28, 2023

Stryker Corporation Provides Earnings Guidance for the Year 2023

Stryker Corporation to Report Q4, 2022 Results on Jan 31, 2023

Stryker Launches Citrefix™ Suture Anchor System

Stryker Corporation Declares Quarterly Dividend, Payable January 31, 2023

Stryker Opens the OR of the Future for Customers to Experience Tomorrow's OR

Stryker Corporation Provides Earnings Guidance for the Year 2022

Stryker Corporation Launches Monterey AI Interbody System with New Pre-Clinical Data

Stryker Launches Q Guidance System with Spine Guidance Software

Upcoming dividend of US$0.69 per share

Stryker Receives FDA Clearance for OptaBlate Bone Tumor Ablation System

Stryker Launches Pulse Intelligent Delivery Platform

Stryker Launches New Gamma4 Hip Fracture Nailing System

Stryker Declares Quarterly Dividend, Payable on October 31, 2022

Stryker Corporation Provides Earnings Guidance for the Full Year of 2022

Second quarter 2022 earnings released: EPS: US$1.73 (vs US$1.57 in 2Q 2021)

Stryker Corporation to Report Q2, 2022 Results on Jul 26, 2022

Upcoming dividend of US$0.69 per share

Lieff Cabraser & Shavitz Law Group Files Federal Collective and California Class Action Lawsuit Against Stryker Corporation for Failure to Pay Overtime Wages, Provide Meal and Rest Breaks, and Pay Business Expenses

Stryker Receives FDA Clearance for Q Guidance System for Spine Applications

Stryker Corporation Announces Board Changes

Stryker Corporation Declares Quarterly Dividend, Payable July 29, 2022

First quarter 2022 earnings released: EPS: US$0.85 (vs US$0.80 in 1Q 2021)

Stryker Corporation to Report Q1, 2022 Results on Apr 28, 2022

Upcoming dividend of US$0.69 per share

Stryker Launches PROstep™ MICA® SOLO Guide

Stryker Corporation (NYSE:SYK) completed the acquisition of Vocera Communications, Inc. (NYSE:VCRA).

Stryker Declares Quarterly Dividend, Payable April 29, 2022

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Stryker Announces New Tornier Perform® Patient-Matched Primary Reversed Glenoid

Stryker Corporation (NYSE:SYK) signed a definitive agreement to acquire Vocera Communications, Inc. (NYSE:VCRA) for $2.9 billion.

Upcoming dividend of US$0.69 per share

VP & CFO recently sold €536k worth of stock

Independent Director recently sold €229k worth of stock

Third quarter 2021 earnings released: EPS US$1.16 (vs US$1.65 in 3Q 2020)

Upcoming dividend of US$0.63 per share

Stryker Corporation (NYSE:SYK) acquired Gauss Surgical, Inc.

Stryker Launches T2 Alpha Femur Retrograde Nailing System

Stryker Launches SurgiCount+ Safety-Sponge System

VP & Chief Legal Officer recently sold €247k worth of stock

Second quarter 2021 earnings released: EPS US$1.57 (vs US$0.22 loss in 2Q 2020)

Stryker Introduces Tornier Shoulder Arthroplasty Portfolio and Launches New Tornier Perform Humeral System

Upcoming dividend of US$0.63 per share

Independent Director has left the company

Insider recently sold €1.1m worth of stock